Genetron Holdings Limited IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Genetron Holdings Limited | GTH - NASDAQ |
$11.50-$13.50 | $16.00 | $16.15 | 16 million ADSs | 6/19/2020 |
| Credit Suisse, CICC | ||||||
Co-Manager(s): BTIG, Canaccord Genuity | ||||||
| Health Care | ||||||
Filing(s): Updated Prospectus 2020-06-04 Filed 2019-11-21 Terms Added 2020-06-15 Amended Terms 2020-06-18 | ||||||
Genetron Holdings Limited Quote & Chart - Click for current quote - GTH
IPO Boutique aggregates information on public companies and private companies, such as "GTH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Genetron Holdings Limited (adapted from Genetron Holdings Limited prospectus):
They are a leading and fast-growing precision oncology company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a leading and fast-growing precision oncology company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "GTH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.